Gilead said it plans to produce more than 2 million treatment courses of the drug by the end of the year and anticipates being able to make “several million more” in 2021. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.